GenBio Inc has discovered and refined a natural compound that overcomes the limitations of many natural compounds in that it is both highly bioactive and non-toxic
Preliminary investigation and fractionation uncovered a compound highly effective as an anti-inflammatory agent. The company also intends to refine the compound and the extract and take it into a second clinical indication: obesity
Our pre-clinical programs draw on teams of highly qualified specialists from several USA based laboratories undertaking focused research into inhibiting target mechanisms of actions, including COX-2, LOX-5 and LOX-15